We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.02%
AUM
$1.88B
AUM Growth
+$96.4M
Cap. Flow
+$24.5M
Cap. Flow %
1.3%
Top 10 Hldgs %
12.98%
Holding
2,267
New
450
Increased
725
Reduced
692
Closed
392

Top Buys

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$13.6M
2
XOM icon
ExxonMobil
XOM
+$10.3M
3
IBM icon
IBM
IBM
+$10.3M
4
AMZN icon
Amazon
AMZN
+$9.32M
5
USB icon
US Bancorp
USB
+$7.89M

Sector Composition

Rank Sector Weight
1 Technology 13.87%
2 Financials 13.85%
3 Consumer Discretionary 12.52%
4 Industrials 12.07%
5 Healthcare 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SID icon
1676
Companhia Siderúrgica Nacional
SID
$1.31B
$104K 0.01%
42,566
+30,931
+266% +$79.8K
NE
1677
DELISTED
Noble Corporation
NE
$104K 0.01%
23,065
+977
+4% +$4.05K
NGNE icon
1678
Neurogene
NGNE
$656M
$103K 0.01%
+437
New +$102K
VMC icon
1679
Vulcan Materials
VMC
$34.8B
$103K 0.01%
800
+218
+37% +$26.6K
DISCK
1680
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$103K 0.01%
4,847
-42,273
-90% -$778K
ELLI
1681
DELISTED
Ellie Mae Inc
ELLI
$103K 0.01%
1,150
+271
+31% +$24K
NLSN
1682
DELISTED
Nielsen Holdings plc
NLSN
$102K 0.01%
2,800
+1,300
+87% +$49.4K
BTE icon
1683
Baytex Energy
BTE
$3.25B
$100K 0.01%
+33,195
New +$97.8K
ERF
1684
DELISTED
Enerplus Corporation
ERF
$98K 0.01%
9,946
-1,781
-15% -$16.3K
CF icon
1685
CF Industries
CF
$19.2B
$97K 0.01%
2,283
+58
+3% +$2.19K
CHRS icon
1686
Coherus Oncology
CHRS
$217M
$97K 0.01%
+11,033
New +$118K
RYAM icon
1687
Rayonier Advanced Materials
RYAM
$604M
$97K 0.01%
4,727
+2,506
+113% +$42.1K
JBLU icon
1688
JetBlue
JBLU
$2.28B
$96K 0.01%
4,304
-45,049
-91% -$920K
CLF icon
1689
Cleveland-Cliffs
CLF
$6.57B
$95K 0.01%
13,138
-73,857
-85% -$491K
ARNA
1690
DELISTED
Arena Pharmaceuticals Inc
ARNA
$94K 0.01%
2,753
-4,052
-60% -$115K
GPRE icon
1691
Green Plains
GPRE
$1.18B
$93K ﹤0.01%
5,494
OVV icon
1692
Ovintiv
OVV
$17.3B
$93K ﹤0.01%
1,400
+234
+20% +$13.8K
CIG icon
1693
CEMIG Preferred Shares
CIG
$6.26B
$92K ﹤0.01%
87,651
-32,048
-27% -$36.4K
WIX icon
1694
WIX.com
WIX
$2.3B
$92K ﹤0.01%
+1,601
New +$99.1K
CNR
1695
Core Natural Resources Inc
CNR
$4.02B
$92K ﹤0.01%
+2,320
New +$67.7K
HIVE
1696
DELISTED
Aerohive Networks
HIVE
$91K ﹤0.01%
+15,583
New +$75.1K
AVDL
1697
DELISTED
Avadel Pharmaceuticals
AVDL
$90K ﹤0.01%
10,982
-6,549
-37% -$61.4K
PVLA
1698
Palvella Therapeutics
PVLA
$1.99B
$90K ﹤0.01%
+150
New +$69.7K
AYI icon
1699
Acuity Brands
AYI
$9.83B
$88K ﹤0.01%
500
+400
+400% +$66.6K
BPMC
1700
DELISTED
Blueprint Medicines
BPMC
$88K ﹤0.01%
1,172
+1,126
+2,448% +$79.2K

Similar funds

Cubist Systematic Strategies's Q4 2017 Portfolio in Review

As of Q4 2017, Cubist Systematic Strategies held 2,267 positions worth $1.88B, up 5.4% from $1.79B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Cubist Systematic Strategies's Q4 2017 filing shows 450 new, 725 increased, 692 reduced and 392 closed positions. Its largest new stake was US Bancorp: 146,673 shares worth $7.86M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $94.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cubist Systematic Strategies's largest Q4 2017 buy was US Bancorp: 146,673 shares worth $7.86M.
  • Cubist Systematic Strategies added most to Boston Scientific in Q4 2017, an estimated $13.6M increase.
  • Cubist Systematic Strategies's biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $94.4M.
  • Cubist Systematic Strategies fully exited Varian Medical Systems, Inc. in Q4 2017, selling an estimated $4.24M.
  • Cubist Systematic Strategies's ten largest holdings make up 13% of its $1.88B portfolio in Q4 2017.
  • Cubist Systematic Strategies opened 450 new positions and closed 392 in Q4 2017.
  • Cubist Systematic Strategies's portfolio value rose 5.4% quarter-over-quarter to $1.88B.

Based on Cubist Systematic Strategies's 13F filing for Q4 2017, filed 14 Feb 2018.